⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL282899 | 1.00 | — | — | |
| SCHEMBL7069443 | 1.00 | — | — | |
| Potassium SCHEMBL30816392 | 0.96 | — | — | |
| SCHEMBL9836842 | 0.96 | — | — | |
| Acetic Acid SCHEMBL733410 | 0.93 | TSHR (0.87) | — | |
| Formic Acid SCHEMBL28114362 | 0.85 | TSHR (0.72) | — | |
| Ethylenediamine SCHEMBL10534337 | 0.85 | NPSR1 (0.72) | — | |
| Butanedione SCHEMBL1424734 | 0.85 | TSHR (0.73) | — | |
| Methacrylic Acid SCHEMBL6307472 | 0.83 | TSHR (0.68) | — | |
| Methacrylic Acid SCHEMBL6307477 | 0.83 | TSHR (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 859 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| EP-4663711-A1 | METHOD OF OBTAINING INSULATING COATING COMPOSITION, COATING COMPOSITION AND CONDUCTIVE MATERIALS COMPRISING THE SAME | Weg Tintas LTDA (BR) | 2025-12-17 | — | — | EP | claimed |
| US-20250353961-A1 | METHOD FOR EXTENSION OF THE SHELF LIFE OF POSITIVE TYPE PHOTOSENSITIVE POLYIMIDE PRECURSORS IN SOLUTION | AKRON POLYMER SYSTEMS INC (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025226939-A1 | ENHANCED SENSATION CONDOM | NUCEPTIVE LABS, INC. (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4608465-A1 | ENHANCED SENSATION CONDOM | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4608466-A1 | STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12297355-B2 | Hybrid crosslinked polymer membrane | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2025-05-13 | — | — | US | claimed |
| US-20250121333-A1 | Advanced carbon molecular sieve membranes derived from composite polyimide hollow fiber precursors | GEORGIA TECH RES INST (US) | 2025-04-17 | — | — | US | claimed |
| CN-119529704-A | Polyurethane composite adhesive film for bonding light down jackets and preparation method thereof | 广东盈通新材料有限公司 | 2025-02-28 | — | — | CN | claimed |
| EP-4499109-A1 | PSYCHEDELIC COMPOSITIONS AND METHODS FOR FORMING THE SAME | Ojai Energetics PBC (US) | 2025-02-05 | — | — | EP | claimed |
| CN-101845272-A | Photocatalytic self-cleaning coating and preparation method thereof | FUJIAN RUISHEN CHEMICAL & ENGINEERING CO LTD | 2010-09-29 | — | — | CN | claimed |
| US-6166032-A | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 2000-12-26 | — | — | US | claimed |
| EP-1014981-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME | Synapse Pharmaceuticals International, Inc. (CA) | 2000-07-05 | — | — | EP | claimed |
| US-5981549-A | Method for controlling or alleviating the symptoms of respiratory disease and allergies | SYNAPSE PHARMACEUTICAL INTERNATIONAL (CA) | 1999-11-09 | — | — | US | claimed |
| US-5916903-A | Method for reducing the effects of antineoplastic disease treatment | SYNAPSE PAHRMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-06-29 | — | — | US | claimed |
| US-5902816-A | Method for treatment of heavy metal poisoning | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-05-11 | — | — | US | claimed |
| US-5900418-A | Method for treatment of obesity | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-05-04 | — | — | US | claimed |
| US-5824684-A | Method for treating drug and alcohol addiction | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-10-20 | — | — | US | claimed |
| WO-1998034615-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-08-13 | — | — | WO | claimed |
| US-5760049-A | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-06-02 | — | — | US | claimed |